[Analysis of reasons for discontinuation of treatment for dyslipidemia in secondary prevention of coronary heart disease].

Objective of the study was retrospective assessment of the reasons of discontinuing the treatment of dyslipidaemias in patients with confirmed coronary heart disease. The study wa on 100 patients (70 M, 30 F, age 30-74 yrs) treated in the Cardiological Center of Ambulatory Diagnostics and Rehabilitation in Wrocław from 01.01.1995 to 01.03.1998. It was shown that the average period of the treatment in Cardiological Center lasted 17.9 months (in the patients who stopped the therapy 13.1 months) and it was not correlated with sex, type of the hyperlipidaemia, the severity of the disease and with type and dosage of the drugs. Cardiosurgical treatment of the coronary heart disease and the age of the patient were the factors correlated significantly with the average period of the lipid-lowering therapy. The absence of a strong (created by the physician) motivation in the patient, and also the deficiency of understanding and his aware agreement for the continuous therapy of the asymptomatic disease, was the main reason of the failure.